Skip to main content

CETIRIZINE

Tracking # 20-1054226

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

CETIRIZINE IS A MEDICATION USED IN THE TREATMENT OF ALLERGIC RHINITIS AND URTICARIA. IT IS A SECOND-GENERATION ANTIHISTAMINE. CETIRIZINE WAS FDA-APPROVED IN THE UNITED STATES AS A PRESCRIPTION-ONLY PRODUCT IN 1995, AND LATER IN 2007, IT GOT APPROVAL AS AN OVER-THE-COUNTER MEDICATION. THIS ACTIVITY REVIEWS THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR CETIRIZINE AS A VALUABLE AGENT IN TREATING RHINITIS AND URTICARIA. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE TREATMENT OF PATIENTS USING CETIRIZINE.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I